Bio-Rad Laboratories, Inc. Class A Common Stock vs Western Alliance Bancorporation — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $298.3 (market cap $8.02B), while Western Alliance Bancorporation trades at $80.41 (market cap $8.79B). The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock and Western Alliance Bancorporation are close in size by market cap, and Western Alliance Bancorporation pays a 2.09% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | WAL | |
|---|---|---|
Market Cap | $8.02B | $8.79B |
Sector | Health | Financials |
52-Week High | $339.75 | $96.08 |
52-Week Low | $241.71 | $66.70 |
Enterprise Value | $7.84B | — |
Dividend Yield | — | 2.09% |
Trailing returns across standard periods
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.
Read more on WAL →